Gambro expands blood range with Sanguistech deal
This article was originally published in Clinica
Executive Summary
Dialysis company Gambro has bought the assets of fellow Swedish company Sanguistech, a subsidiary of SAAB. The deal brings the Orbisac blood separation system and technology to Gambro's blood component division, Gambro BCT.